Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Translational Science

Discovery & Development Drug Discovery

The Next Frontier in HIV Prevention

| Maryam Mahdi

Exploring the potential of vaccines for treatment equity.

Discovery & Development Drug Discovery

The Tale of Two TULIPs

| Angus Stewart

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

Discovery & Development Vaccines

Backwards Vax Moves Forward

| Angus Stewart

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

Discovery & Development Drug Discovery

Completing the Cell Therapy Revolution

| James Strachan

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

Discovery & Development Drug Discovery

Unleashing Cellular Potential

| James Strachan

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.

Business & Regulation Standards & Regulation

Watching the Future

| James Strachan

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

Business & Regulation Drug Delivery

What's New from The Cell + Gene Curator?

| James Strachan

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

Manufacture Analytical Science

Nominations for the 2021 Innovation Awards

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

Discovery & Development Advanced Medicine

Understanding the Three Levels of Genetic Medicine

| James Strachan

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Discovery & Development Advanced Medicine

Don’t Break My Strands

| Emily M. Anderson

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register